Research map: Health care resource utilization and costs in patients with acute myeloid leukemia treated with posttransplant maintenance therapy

Back to the article

Papers in this map

  1. Updating and Validating the Charlson Comorbidity Index and Score for Risk Adjustment in Hospital Discharge Abstracts Using Data From 6 Countries · Hude Quan · 2011 · 6050 citations · Cited by this paper
  2. Health care cost trajectories among patients with cancer and cardiometabolic comorbidities over a decade including the pandemic period · 2026 · Related
  3. A Modification of the Elixhauser Comorbidity Measures Into a Point System for Hospital Death Using Administrative Data · Carl van Walraven · 2009 · 2230 citations · Cited by this paper
  4. Principles and practices for successful gene therapy innovative contracting: Insights from a multistakeholder convening · 2026 · Related
  5. Maintenance therapy with low‐dose azacitidine after allogeneic hematopoietic stem cell transplantation for recurrent acute myelogenous leukemia or myelodysplastic syndrome · Marcos de Lima · 2010 · 433 citations · Cited by this paper
  6. Timing of health technology assessment in the United States: An evaluation of ICER reviews over 8 years · 2026 · Related
  7. comorbidity: An R package for computing comorbidity scores · Alessandro Gasparini · 2018 · 393 citations · Cited by this paper
  8. Incremental health care resource utilization, costs, and predictors of high costs in generalized myasthenia gravis · 2026 · Related
  9. 6. A Diagnostic Routine for the Detection of Consequential Heterogeneity of Causal Effects · Stephen L. Morgan · 2008 · 212 citations · Cited by this paper
  10. Cost-effectiveness analysis of treatment strategies initiating with second-generation antipsychotic long-acting injectables in patients with schizophrenia in the United States · 2026 · Related
  11. Low‐dose azacitidine after allogeneic stem cell transplantation for acute leukemia · Elias Joseph Jabbour · 2009 · 198 citations · Cited by this paper
  12. Incidence of amyloid-related imaging abnormalities and health resource utilization in patients with Alzheimer disease receiving monoclonal antibody treatments: A real-world evidence study · 2026 · Related
  13. Maintenance Therapy with Decitabine after Allogeneic Stem Cell Transplantation for Acute Myelogenous Leukemia and Myelodysplastic Syndrome · Iskra Pusic · 2015 · 164 citations · Cited by this paper
  14. Patient experience data in formulary decision-making: Payer-reported perceptions and use · 2026 · Related
  15. Comparative therapeutic value of post-remission approaches in patients with acute myeloid leukemia aged 40–60 years · Jan J. Cornelissen · 2014 · 132 citations · Cited by this paper
  16. Evaluating the design and implementation challenges of the Centers for Medicare & Medicaid Services’ Cell and Gene Therapy Access Model · 2026 · Related
  17. Maintenance therapy in acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation · Li Xuan · 2021 · 87 citations · Cited by this paper
  18. US commercial health plan use of corticosteroids in step therapy protocols: Frequency and clinical appropriateness · 2026 · Related
  19. Relapse after allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia: an overview of prevention and treatment · Firas Kreidieh · 2022 · 74 citations · Cited by this paper
  20. Advancing the measurement of caregiver impact: Data collection priorities aligned with caregiver, health technology assessment, and policy stakeholders · 2026 · Related
  21. Post‐transplant maintenance therapy with azacitidine and gemtuzumab ozogamicin for high‐risk acute myeloid leukaemia · Gaku Oshikawa · 2014 · 61 citations · Cited by this paper
  22. How I treat with maintenance therapy after allogeneic HCT · Zachariah Michael DeFilipp · 2022 · 46 citations · Cited by this paper
  23. Maintenance therapy with decitabine after allogeneic hematopoietic stem cell transplantation to prevent relapse of high-risk acute myeloid leukemia · Yunju Ma · 2019 · 34 citations · Cited by this paper
  24. Maintenance azacitidine after myeloablative allogeneic hematopoietic cell transplantation for myeloid malignancies · Kathryn T. Maples · 2018 · 33 citations · Cited by this paper
  25. Harnessing the immune system after allogeneic stem cell transplant in acute myeloid leukemia · Cole Harris Sterling · 2020 · 27 citations · Cited by this paper
  26. Economic and Clinical Burden of Relapsed and/or Refractory Active Treatment Episodes in Patients with Acute Myeloid Leukemia (AML) in the USA: A Retrospective Analysis of a Commercial Payer Database · Bhavik J. Pandya · 2019 · 23 citations · Cited by this paper
  27. Post‐transplant maintenance therapy in patients with FLT3‐mutated acute myeloid leukemia: Real‐world treatment patterns and outcomes · James D. Griffin · 2021 · 19 citations · Cited by this paper
  28. Maintenance therapy for AML after allogeneic HCT · Rahul Nayak · 2022 · 10 citations · Cited by this paper
  29. Novel Mechanisms for Post-Transplant Maintenance Therapy in Acute Myeloid Leukemia · Steven Anthony Manobianco · 2022 · 9 citations · Cited by this paper
  30. Allogeneic Hematopoietic Stem Cell Transplantation Improved Survival for Adult Core Binding Factor Acute Myelogenous Leukemia Patients with Intermediate- and Adverse-Risk Genetics in the 2017 European LeukemiaNet · Tanzhen Wang · 2020 · 8 citations · Cited by this paper
  31. Post-transplant maintenance therapy in acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation harmonizing multiple therapeutic modalities including targeted therapy, immunotherapy and cellular therapy · Eshrak Al‐Shaibani · 2023 · 8 citations · Cited by this paper
  32. Post-Transplant Maintenance Therapy in Acute Myeloid Leukemia · Katherine Parks · 2024 · 5 citations · Cited by this paper

Source: OpenAlex (CC0)